F
Femasys Inc (FEMY)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
$1.28
-0.14 (-9.86%)
Market Cap: $11.89M
Last updated: Nov 17, 2026 at 11:05 AM ET
Femasys Inc (FEMY) Valuation Multiples
Femasys (FEMY) trades at 5.6x sales and 0.4x book value. Its P/B of 0.4x is below its 5-year median of 2.7x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 5.6x |
| Price to book | 0.4x |
| EV/FCF | 0.5x |
| PEG | N/A |
| FCF yield | -156.3% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 0.4x | 2.7x | N/A |
Valuation History
Over the 5 year ends shown, its P/S ranged from 8.8x in 2022 to 443.8x in 2021.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $11.52 | 9.9x | 5.2x |
| 2024 | $22.00 | 15.0x | 4.1x |
| 2023 | $19.50 | 14.0x | 1.4x |
| 2022 | $18.00 | 8.8x | 0.6x |
| 2021 | $78.00 | 443.8x | 32.1x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About FEMY
Is FEMY stock overvalued?
GNG's valuation label for FEMY is Undervalued.
What is FEMY's price to sales ratio?
Femasys has a price to sales ratio of 5.6x.
FEMY pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors